These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28931435)

  • 1. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
    Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis.
    Hu R; Yang X; He X; Song G
    Lipids Health Dis; 2023 Jan; 22(1):8. PubMed ID: 36670387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
    Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
    Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study.
    Chen X; Shen T; Li Q; Chen X; Li Y; Li D; Chen G; Ling W; Chen YM
    Sci Rep; 2017 Mar; 7():45100. PubMed ID: 28332619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
    Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
    [TBL] [Abstract][Full Text] [Related]  

  • 7.  Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Polymerou V; Papadimitriou KG; Zavos C; Katsinelos P
    Ann Hepatol; 2016; 15(5):705-14. PubMed ID: 27493109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
    Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
    Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.
    Alkhouri N; Lopez R; Berk M; Feldstein AE
    J Clin Gastroenterol; 2009; 43(10):985-9. PubMed ID: 19525859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Makri E; Orfanidou M; Makri ES; Goulas A; Terpos E; Polyzos SA
    J Clin Exp Hepatol; 2024; 14(3):101353. PubMed ID: 38435724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
    Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between retinol-binding protein 4 and prediabetes in obese patients with nonalcoholic fatty liver disease.
    Karamfilova V; Gateva A; Alexiev A; Zheleva N; Velikova T; Ivanova-Boyanova R; Ivanova R; Cherkezov N; Kamenov Z; Mateva L
    Arch Physiol Biochem; 2022 Feb; 128(1):217-222. PubMed ID: 31588816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.
    Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y
    Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
    Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis.
    Liu Y; Mu D; Chen H; Li D; Song J; Zhong Y; Xia M
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4338-4348. PubMed ID: 27504850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.